药物管理训练对精神分裂症患者的影响

Clinical Influence of Drug Management Training on Patients with Schizophrenia

目的:探讨药物管理训练对精神分裂症患者服药依从性和疾病预后影响的实践研究。方法:选择2017年6月至2018年8月于河源市精神卫生中心治疗的精神分裂症患者80例作为研究对象,采用随机数字表将患者分为对照组(n=40)和观察组(n=40)。对照组患者采用常规药物治疗和护理干预,观察组患者在对照组基础上加药物管理训练。1个月后对两组的效果进行评估,比较两组患者训练前、训练后、出院后、出院后1个月的服药态度和服药依从性。结果:两组患者训练前服药态度评分比较,差异无统计学意义(P> 0.05),观察组患者训练后、出院1个月、出院1年的服药态度评分均显著优于对照组,差异具有统计学意义(P <0.05)。经1个月训练后,观察组患者服药依从性显著优于对照组,差异具有统计学意义(P <0.05)。结论:将药物管理训练运用在精神分裂症患者中,能提高患者服药依从性,减少病情复发,安全性高。

Objective To explore the clinical influence of drug management training on patients with schizophrenia. Methods 80 patients with schizophrenia treated from June 2017 to August 2018 in Heyuan mental health center were selected. Divided into the control group(n = 40) and the observation group(n = 40) by random number table. The control group received conventional drug therapy and nursing intervention, and observation group given drug management training on the basis of control group. Evaluated effect were compared after 1 month. Results There were no statistically significant difference between the two groups of patients before training(P > 0.05). The attitudes of patients in the observation group after training, 1 month after discharge, and 1 year after discharge were significantly better than the control group(P < 0.05). After one month of training, the compliance of patients in the observation group was significantly better than that in the control group. The difference was statistically significant(P < 0.05). Conclusion Applied to drug management training to schizophrenia, can improve patients’ compliance, reduce recurrence, and high safety, worthy of popularization and application.